In this issue:
Effect of catch-up HPV testing
POLE hotspot test to improve prognosis of EC
Impacts of long waiting periods for radiotherapy
Antitumour activity produced by pertuzumab plus trastuzumab
Predictors of QoL undergoing surgical staging
Risk of interstitial lung disease from PARPi
Efficacy and safety of chemoradiotherapy plus H101 injection
Effectiveness of carboplatin as second line treatment
Success rate of intraoperative injection radiotracer
Role of nintedanib in cervical cancer
Please login below to download this issue (PDF)